Beyond the Buyout: Unpacking the Supply Chain’s Role in Pharma M&A Success

6 min read

A minimalistic image of a chain of pills of different colors, linking together and sparking light. Each pill distinctly colored

Explore how 2024’s M&A trends in pharma, spotlighted by the JPMorgan Conference, emphasize supply chain mastery for innovation and market success January 8, 2024, marked a significant start at the JPMorgan Healthcare Conference. This day set the tone for the year in the healthcare sector, especially for mergers and acquisitions (M&A). This conference is a big deal. It shows us the trends and what might happen next in healthcare. Looking at how the market responded, it’s reasonable to ask a straightforward question: What are investors saying about these big deals? We’re diving into this question. We want to understand what investors think about the companies…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.